Characterisation of heart failure with normal ejection fraction in a tertiary hospital in Nigeria.

BMC Cardiovascular Disorders
Adedeji K AdebayoAyodele O Falase

Abstract

The study aimed to determine the frequency and characteristics of heart failure with normal EF in a native African population with heart failure. It was a hospital cohort study. Subjects were 177 consecutive individuals with heart failure and ninety apparently normal control subjects. All the subjects underwent transthoracic echocardiography. The group with heart failure was further subdivided into heart failure with normal EF (EF > or = 50) (HFNEF) and heart failure with low EF(EF <50)(HFLEF). The subjects with heart failure have a mean age of 52.3 +/- 16.64 years vs 52.1 +/- 11.84 years in the control subjects; p = 0.914. Other baseline characteristics except blood pressure parameters and height were comparable between the group with heart failure and the control subjects. The frequency of HFNEF was 39.5%. Compared with the HFLEF group, the HFNEF group have a smaller left ventricular diameter (in diastole and systole): (5.2 +/- 1.22 cm vs 6.2 +/- 1.39 cm; p < 0.0001 and 3.6 +/- 1.24 cm vs 5.4 +/- 1.35 cm;p < 0.0001) respectively, a higher relative wall thickness and deceleration time of the early mitral inflow velocity: (0.4 +/- 0.12 vs 0.3 +/- 0.14 p < 0.0001 and 149.6 +/- 72.35 vs 110.9 +/- 63.40 p = 0.001) respectively. Th...Continue Reading

References

Mar 1, 1990·Progress in Cardiovascular Diseases·J C Stauffer, W H Gaasch
Jun 1, 1989·Circulation·W Y Lew
Feb 15, 1986·The American Journal of Cardiology·R B DevereuxN Reichek
Dec 1, 1995·Journal of the American College of Cardiology·R S VasanD Levy
Mar 15, 1995·Journal of the American College of Cardiology·H M KrumholzD Levy
Apr 23, 1999·European Heart Journal·M R CowieG C Sutton
Jan 5, 2000·BMJ : British Medical Journal·R C DavisG Y Lip
Jan 4, 2001·The New England Journal of Medicine·S K GandhiW C Little
Feb 17, 2001·The American Journal of Cardiology·D W KitzmanUNKNOWN Cardiovascular Health Study Research Group
Feb 24, 2001·Clinical Cornerstone·M R Zile, J M Simsic
Apr 5, 2001·European Heart Journal·J G ClelandA Clark
Jan 5, 2002·Journal of the American College of Cardiology·Prithwish BanerjeeJohn G F Cleland
Jan 16, 2002·Heart Failure Reviews·Dalane W Kitzman
Feb 1, 2003·European Journal of Heart Failure·Bassem S Ibrahim
Mar 8, 2003·The American Journal of Geriatric Cardiology·Ali AhmedJames F DeLong
May 16, 2003·The New England Journal of Medicine·Mariell Jessup, Susan Brozena
Dec 25, 2003·Diabetes Care·UNKNOWN American Diabetes Association
Mar 12, 2004·Journal of the American College of Cardiology·Karen HoggJohn McMurray
Apr 20, 2004·Journal of the American College of Cardiology·Marc KlapholzUNKNOWN New York Heart Failure Consortium
May 7, 2004·The New England Journal of Medicine·Michael R ZileWilliam H Gaasch
Jan 3, 2006·Heart·J E Sanderson
Jan 18, 2006·Journal of the American Medical Directors Association·Wilbert S Aronow
Nov 7, 2006·Progress in Cardiovascular Diseases·Dirk L Brutsaert

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır
Muzaffer DeğertekinOmer Kozan
Vojnosanitetski pregled. Military-medical and pharmaceutical review
Dragana StanojevićDusanka Kutlesić-Kurtović
© 2022 Meta ULC. All rights reserved